การลด Zygoma (Malarplasty)

What zygoma reduction is (and is not)

Zygoma reduction narrows cheekbone projection through osteotomy (controlled bone cutting) of the zygomatic complex. The procedure addresses two distinct projections: the malar projection (the front of the cheekbone, prominent in three-quarter and frontal views) and the arch projection (the lateral cheekbone extending toward the ear, prominent in profile and frontal views).

Standard surgical techniques in current Korean practice:

• L-osteotomy — L-shaped cut of the zygomatic body through intraoral access. The freed segment is repositioned medially and fixed with plates and screws. Korean clinics also market a "High-L osteotomy" variant placing the horizontal cut higher on the zygoma for more substantial reduction; the technique is a refinement of the standard L approach with a different cut height rather than a fundamentally different procedure.
• I-osteotomy — Single-line cut of the zygomatic body. Simpler than L-osteotomy; less control over segment positioning.
• Zygomatic arch osteotomy — Cut of the zygomatic arch (lateral portion near the ear) through a small preauricular or sideburn-area incision. Required for cases with substantial lateral arch projection.
• Combined L-osteotomy + arch osteotomy — The standard Korean technique for substantial-projection cases. Addresses both malar and arch components in one operation.
• Intraoral-only approaches — Avoid the preauricular incision but cannot adequately address arch projection. Suitable only for cases with primarily malar (front) projection without significant lateral component.
• Burring (without osteotomy) — Less common; reduces surface projection without segment repositioning. Limited in maximum reduction; sometimes used for minor refinement or revision.

Fixation:

• Rigid plate-and-screw fixation (current standard) — Stabilizes the repositioned segment during healing. Standard at premium-tier Korean clinics.
• Wire fixation (older approach) — Less rigid; less commonly used in current practice.
• Resorbable plate fixation — Avoids long-term hardware presence but with higher cost and somewhat lower rigidity. Not all clinics offer this.

Zygoma reduction is not the same as facial fat reduction or buccal fat removal. Buccal fat removal addresses fullness in the lower cheek region; zygoma reduction addresses bony projection in the upper cheek region. Patients with lower-cheek fullness rather than upper-cheek bone projection should consider buccal fat removal or related procedures.

It is also not the same as masseter botox or mandible angle reduction. Masseter botox addresses muscle-driven jaw width; mandible angle reduction addresses bone-driven lower jaw width; zygoma reduction addresses cheekbone width specifically. The three procedures address different anatomical concerns and are sometimes combined in a comprehensive contouring plan.

What patients actually report

Our reviews database holds limited Korean-clinic zygoma reduction entries directly tagged. Patterns below are aggregated from international forums (RealSelf reduction malarplasty boards, Korean platforms), Korean clinic case series, and peer-reviewed satisfaction literature.

Outcome measurement matters more than patients expect. Cheekbone width changes are subtle in absolute millimeters but substantial in cosmetic perception. Reviewers whose pre-op consultation included 3D imaging or clear photographic markup of planned reduction describe satisfaction with the outcome; reviewers without that grounding sometimes describe the result as 'not enough' even when objective reduction was substantial.

Combined V-line surgery satisfaction varies with case appropriateness. Reviewers with concerns in all three zones (zygoma + mandible + chin) who underwent combined V-line surgery describe transformative results. Reviewers with primary concerns in one or two zones who were sold the full V-line package report mixed satisfaction; the additional zones added recovery burden without proportional cosmetic benefit.

Post-op cheek ptosis is the most-cited dissatisfaction. Reviewers reporting visible midface sagging at 6+ months describe this as the most-impactful negative outcome. Older patients (40+) at the time of surgery report higher rates than younger patients. Pre-op risk discussion at consultation is the differentiator; reviewers whose surgeons explicitly discussed ptosis risk feel adequately informed even when the outcome occurs.

Hardware-related issues are typically minor but emotionally meaningful. Reviewers describe hardware sensitivity (cold-temperature awareness, palpable plates), occasional gum exposure, and electively-pursued hardware removal at 6–12 months. The Korean specialist response to these is generally good (revision available, hardware removal as outpatient), but patients should expect this to be part of the long-term picture.

The filtered zygoma reduction reviews show what we have today.

Cautions from clinical practice

Zygoma reduction has a substantial complication profile. The publicly reported issues span surgical complications (bleeding, infection, anesthesia), nerve-related issues, hardware-related issues, and aesthetic-outcome issues (ptosis, asymmetry, residual projection).

Infraorbital nerve injury. The infraorbital nerve (sensation to lower eyelid, lateral nose, upper lip, anterior cheek) exits the maxilla just below the inferior orbital rim and can be affected during zygomatic body osteotomy. Reported temporary numbness rates are common; permanent partial numbness occurs in 5–15% of cases in trained-hand cohorts, with higher rates in poor-technique cases or large reductions.

Facial nerve injury. Branches of the facial nerve (especially the temporal branch supplying the frontalis and orbicularis oculi) can be affected during zygomatic arch osteotomy through the preauricular incision. Reported temporary injury rates run 2–8%; permanent injury under 1%. Effects can include forehead asymmetry on raising eyebrows or weakness in eye closure.

Post-op cheek ptosis (soft-tissue sagging). The signature complication of zygoma reduction. When the bony platform is moved medially, the soft tissue sitting on it may sag rather than redrape, producing visible cheek hollowing or midface sagging at 6+ months. Reported rates run 5–15% with appropriate technique; higher with aggressive reductions or in older patients. Some surgeons add midface suspension sutures or fat grafting to mitigate; the risk is not fully eliminable.

Bony asymmetry. Differential reduction or repositioning between sides produces asymmetric outcome at 6 months. Reported in 5–10% of cases. Mild cases accepted; significant cases may need revision (more difficult than primary surgery). Note that minor bony gaps visible on post-operative CT scans (under 3mm) are normal expected findings — bone bridges across these gaps during healing — and do not represent malunion.

Malunion or nonunion. Failed bone healing at the osteotomy sites. Rare (under 2%) but serious; may require revision surgery.

Hardware exposure. Plates and screws may become exposed through the intraoral gum tissue. Reported in 2–8% of cases. Minor exposures may be left until bone healing is complete (12+ months) and then removed; significant exposures need earlier intervention.

Hardware sensitivity. Some patients describe palpable plates, cold-temperature sensitivity, or general awareness of the hardware. Elective hardware removal at 12+ months is common; required removal occurs in under 5% of cases.

TMJ issues. Disruption of the zygomatic arch can affect the temporomandibular joint (TMJ) function. Reported rates 5–15% transient (typically jaw stiffness or tightness for the first 4–6 weeks rather than permanent joint damage); 1–3% chronic. Most transient cases resolve as swelling decreases and normal jaw motion returns.

Bleeding. Significant intra-operative bleeding is uncommon but possible from the deep facial vessels near the zygomatic arch. Severe cases require transfusion in under 2% of cases.

Infection. Reported under 2% with standard antibiotic prophylaxis.

Residual projection / under-correction. Reported in 3–10% of cases; addressable by revision surgery, which is meaningfully harder than primary surgery.

Aesthetic outcome dissatisfaction. Even with successful bony reduction, the cosmetic outcome may not match patient expectation. Pre-op planning with 3D imaging or clear photographic markup reduces this rate.

The technique decision tree

The right technique depends on the patient's specific projection pattern and reduction goals.

Patients should ask explicitly which technique combination is recommended, what's driving each decision, and what alternatives the surgeon considered. Korean specialist clinics typically articulate this clearly; clinics that can't are operating in template mode.

Cost in Gangnam

Zygoma reduction pricing in Korean clinics depends on technique scope, combined procedures, and surgeon seniority. The numbers below are clinic-quoted ranges as of 2026:

For comparison: equivalent zygoma reduction in the US is largely unavailable or limited to a small number of specialist plastic surgeons charging premium rates ($15,000–$30,000+); in the UK and Australia similar limited availability. The procedure is largely a Korean specialty, and the cost differential combined with surgeon-volume differential makes Korea the dominant destination for international patients pursuing meaningful zygoma reduction. The trip math is favorable.

Recovery, day by day

Zygoma reduction recovery is meaningful. The procedure-day-to-final-result arc spans 6–12 months for full settlement.

Trip duration: minimum 14-day stay (procedure + 12 days recovery + clearance to fly); optimal 21-day stay particularly for combined V-line cases. The recovery is similar in scope to other major facial bone procedures.

The 10 questions to ask in your consultation

Suggested questions for your zygoma reduction consultation. The technique-decision, ptosis-risk, and combined-procedure questions are the highest-impact decisions.

1. Are you using L-osteotomy or I-osteotomy, and intraoral-only or combined with arch osteotomy? Why for my case? The answer should reference your specific projection pattern (malar vs arch) and reduction magnitude.
2. What's the planned reduction in mm at the malar and arch points? Specific numbers should be available; vague 'natural reduction' answers are not adequate for a bone procedure.
3. What's my ptosis-risk profile, and what's your protocol for mitigation? Age, skin elasticity, and reduction magnitude all factor in. Honest answer references explicit risk discussion plus mitigation options (midface suspension sutures, fat grafting, conservative reduction).
4. What's your reported infraorbital nerve injury rate, and what's your protocol if numbness develops? Specialist clinics may have published or internal data.
5. If I'm considering combined V-line surgery (zygoma + mandible + chin), what's the case for combining vs staging? Honest answer addresses cumulative recovery burden and operating-room time concerns, not just convenience.
6. What hardware are you using (titanium rigid, resorbable, wire), and what's your removal protocol? Clinic should reference patient preference and removal logistics.
7. What 3D imaging or photographic planning are you using to communicate the planned outcome? Should be more than verbal description for a substantial bone procedure.
8. Who personally performs the osteotomies and segment positioning? Senior surgeon involvement throughout matters here.
9. What's the all-in price including consultation, surgery, hospital stay, anesthesia, hardware, post-op care, and follow-up? Get the full-stack number; itemize hardware-removal cost if relevant.
10. What's your revision protocol if I have asymmetry, residual projection, or significant cheek ptosis at 6–12 months? The clinic's framing reveals whether they're operating in long-arc outcome mode.

Choosing a clinic

Zygoma reduction is offered primarily by specialist craniofacial-and-contouring clinics in Gangnam. The procedure is technically demanding enough that surgeon volume matters more here than for many K-beauty procedures.

• Board-certified plastic surgeon with specific zygoma reduction case volume — typically over 100 zygoma reductions annually for premium-tier specialist clinics. The procedure is concentrated in fewer clinics than general K-beauty work.
• Documented technique and outcome protocols — pre-op CT or 3D imaging, photographic standardization, intra-operative documentation, post-op tracking at 3, 6, 12 months.
• Modern technique availability — combined intraoral-plus-arch capability; clinics offering only intraoral-only may be appropriate for limited cases but not for substantial-projection cases.
• Explicit ptosis-mitigation protocols — midface suspension or fat-grafting integration capability; clinic philosophy on conservative vs aggressive reduction.
• Hospital-grade operating facility with overnight observation — appropriate for the surgical scope.
• Senior-surgeon-led teams — the procedure is too technical for technician-driven execution.
• Realistic candidacy assessment — clinics that propose aggressive reduction without addressing ptosis risk in older patients may be operating in surgery-volume mode.
• Combined V-line capability where appropriate — clinics that can offer the combined V-line case in single anesthesia event are valuable for combined-indication patients but should also recommend single-zone procedures when appropriate.

The filtered clinic directory shows current matches. The shortlist for zygoma reduction should be meaningfully narrower than for general K-beauty.

Risks, complications, and what a safe clinic looks like

The published AE rates for zygoma reduction in trained Korean specialist hands sit roughly here: infraorbital nerve permanent injury 5–15%; facial nerve injury 2–8% temporary, under 1% permanent; cheek ptosis (soft-tissue sagging) 5–15%; bony asymmetry 5–10%; malunion or nonunion under 2%; hardware exposure 2–8%; hardware sensitivity (palpable plates) 10–20%; TMJ complications 5–15% transient, 1–3% chronic; bleeding requiring transfusion under 2%; infection under 2%; residual projection 3–10%; aesthetic dissatisfaction 5–15%.

Recognition. Patient-side signals worth knowing: significant unilateral swelling, redness, fever in first 2 weeks (potential infection — needs immediate clinic contact); rapid expansion of swelling beyond day 5 (uncommon — rule out hematoma); persistent severe pain not responding to medication (atypical); inability to fully close eye or weakness raising eyebrow on one side (potential temporal branch facial nerve injury); persistent severe numbness in upper lip / lower eyelid / lateral nose at 12+ months (likely permanent infraorbital nerve injury); visible cheek hollowing or midface sagging at 6+ months (cheek ptosis).

Documentation. Pre-procedure 3D imaging (CT or CBCT); pre-op clinical photos in standardized angles; planned reduction in mm at multiple points; intra-operative documentation; post-op imaging; clinical photos at 1 week, 6 weeks, 3 months, 6 months, 12 months. Clinics that maintain this protocol are operating in research-grade mode.

Safety considerations specific to international medical tourism. The 14-day minimum stay is non-negotiable. The hospital stay (typically 1–2 nights for standalone, 2–3 nights for combined V-line) catches early complications; the day 1–2 clinic check stabilizes the patient enough to outpatient; the day 10–14 check before flying catches lingering issues. Patients flying home before day 14 risk early-detection misses on infection, hardware issues, or asymmetry signs. Long-distance follow-up via remote photo and video submission works for the long-arc visits at month 3, 6, 12.

Who is a good candidate (and who is not)

Zygoma reduction has well-defined candidacy. The ideal candidate is age 20+ with completed skeletal growth, with substantial cheekbone projection at malar or arch component (or both), with appropriate skin elasticity for the planned reduction (younger patients have lower ptosis risk), in good general health, with realistic expectations grounded in the 6–12 month outcome timeline, and willing to commit to the substantial recovery and complication risk.

Reasons to delay or skip:

• Active skeletal growth (under 18 typically). Surgery before growth completion can have continued growth disrupting the result.
• Mild projection only. Patients with mild cheekbone projection may be better served by non-surgical alternatives (filler-based contouring) or non-treatment.
• Older age (over 50) with reduced skin elasticity. Cheek ptosis risk is significant in this group; honest consultation may recommend alternatives or staged approaches with explicit ptosis-mitigation.
• Significant medical comorbidities. Active autoimmune conditions, bleeding disorders, severe cardiovascular disease, or other systemic conditions require evaluation and stabilization.
• Active smoking. Smoking impairs bone healing and increases complication rates; cessation 4–8 weeks pre and post procedure typically required.
• Unrealistic expectations. Patients seeking dramatic transformation that exceeds anatomical possibility are mismatched in expectation.
• Body dysmorphia or unstable body-image expectations. Repeated revision-seeking patterns warrant pre-surgical psychological assessment.
• Pregnancy or planned pregnancy in the next 12 months. Postpone elective surgery.
• Unable or unwilling to commit to 14-21 day stay and 6+ month outcome timeline. The procedure is not appropriate for compressed-timeline tourism.

For older patients (over 40) considering zygoma reduction: the ptosis-risk discussion is critical. Mitigation options (midface suspension sutures, simultaneous fat grafting, conservative reduction) should be discussed explicitly. Combined approaches (zygoma reduction plus face lift in different operations or staged) may be appropriate for some cases.

When to travel and how long to stay

Zygoma reduction requires a meaningfully longer stay than non-surgical procedures because the early recovery checkpoints matter and the soft-diet transition takes time.

Minimum: 14 days. Procedure (Day 1) + hospital observation (1–2 nights for standalone, 2–3 nights for combined V-line) + outpatient recovery in hotel + clearance to fly. Tight but feasible for standalone zygoma cases.

Optimal: 21 days. Procedure + extended recovery + 2–3 clinic checks + more relaxed recovery before flying. Most international patients should plan for this length, particularly for combined V-line cases.

Long-arc follow-up: 1, 3, 6, 12 month checks, typically managed via remote photo and video submission. The 6-month and 12-month checks are the most important; some patients return in person for the 12-month check coinciding with elective hardware removal if pursued.

Combination trips: Zygoma reduction combines naturally with mandible angle reduction and chin reduction in the V-line bundle (single anesthesia event). Combining with major non-bony procedures (rhinoplasty, breast surgery) is possible but adds anesthesia time and recovery burden; should be evaluated case-by-case.

Touch-up sessions: If revision becomes needed (asymmetry, residual projection, significant ptosis), typically scheduled 6–18 months out. Most revisions require a second separate trip and may be more invasive than the original procedure.

Hardware removal: Routinely scheduled at 12+ months as outpatient procedure under sedation. Some patients combine with another planned Korea trip; others come specifically for hardware removal as a 3–5 day visit.

Tax refund, cash discount, and seasonal deals

Three layers of price reduction stack at most clinics:

VAT refund. Up to 10% of the procedure cost, recoverable at Incheon Airport for foreigners on tourist visas — but only at clinics registered with Korea's Medical Tourist Tax Refund program. Cosmetic zygoma reduction generally qualifies. Either Global Tax Free or KT Tourism Tax Refund handles most refunds. The tax refund calculator shows what you'll actually recover after fees.

Cash discount. Typically 5–10%. On a ₩10,000,000 ($7,600) zygoma reduction, this is ₩500,000–₩1,000,000 ($380–$760).

Seasonal promotions. Less common for substantial bone procedures than for non-surgical work. Some clinics offer modest discounts on combined V-line packages or off-peak scheduling.

Currency exchange: Pricing in KRW is typically locked at booking. Patients booking 3–6 months ahead can occasionally benefit from favorable USD-to-KRW movement; the inverse risk is also real.

Alternatives to consider instead

Zygoma reduction is the right answer for substantial cheekbone projection of skeletal origin in appropriate candidates. If your case is something else, consider these alternatives:

• Mild projection or non-skeletal cheek fullness. Filler-based contouring (placing filler in the temple, lower cheek, or jawline to balance midface proportions without bone reduction) can produce meaningful aesthetic improvement without surgical risk. Not equivalent for substantial bony projection but often the right answer for mild cases.
• Lower-cheek fullness rather than upper-cheek bone projection. Buccal fat removal addresses lower-cheek soft tissue; addresses a different anatomical concern than zygoma reduction.
• Older patients with significant ptosis risk. Combined approaches (zygoma reduction plus face lift; or face lift first followed by reduction; or non-surgical alternatives) may be appropriate. Some older patients are best served by skipping reduction entirely and pursuing other rejuvenation work.
• Substantial reduction goals exceeding anatomical safety. Patients seeking reduction beyond what infraorbital-nerve preservation and rigid-fixation requirements allow are mismatched with surgical possibility; conservative reduction or non-treatment is appropriate.
• Bone-driven jaw width concerns rather than cheek width. Mandible angle reduction (square jaw reduction) addresses a different anatomical zone; sometimes confused with zygoma reduction.
• Asymmetry-correction primary concern without overall projection. Targeted asymmetry correction may differ from comprehensive cheekbone reduction; surgeon should articulate the difference.
• Non-treatment. Some patients reassess after consultation and choose to live with their natural anatomy. This is a legitimate outcome, particularly when projection is mild and complication-risk profile is high (older age, smoking, comorbidities).

A serious zygoma reduction consultation will sometimes recommend filler-based alternatives, combined approaches, or non-treatment. That signals an outcome-focused practice rather than a surgery-volume operation.

The bottom line

The case for Gangnam for zygoma reduction is among the strongest of any K-beauty procedure. The procedure was developed and refined in Korean and Japanese cosmetic practice over the past three decades; the per-surgeon experience and per-clinic case volume in Gangnam exceed most other markets by a substantial margin. The procedure is largely unavailable or available only at premium specialist rates in Western markets — patients pursuing meaningful zygoma reduction often find that home-country options are limited or significantly more expensive. The cost differential combined with surgeon-volume differential makes Korea the dominant destination for international patients pursuing this specific indication.

The case against rests on the procedure's substantial complication profile. Cheek ptosis at 6+ months is a distinctive risk that affects 5–15% of cases in trained hands and is largely irreversible without revision. Infraorbital nerve permanent partial numbness occurs in 5–15%. Hardware-related concerns affect a meaningful subset of patients long-term. The recovery is substantial (14–21 day stay; 6–12 month outcome timeline) and the procedure is not appropriate for compressed-timeline tourism.

The patients for whom Gangnam zygoma reduction is most clearly the right call are those with substantial cheekbone projection at malar or arch component (or both); appropriate skin elasticity (typically under 40 for lowest ptosis risk; older patients require explicit ptosis-mitigation discussion); willingness to commit to 14–21 day stay; comfortable with the substantial complication profile relative to non-bone procedures; and origins where flight cost is not prohibitive relative to absolute savings vs limited Western availability. Combined V-line candidates (zygoma + mandible + chin in same operation) get particularly strong cost-and-experience benefits.

For patients with mild projection, primarily soft-tissue rather than bony fullness, or significant age-related ptosis-risk concerns: less-invasive alternatives (filler contouring, buccal fat removal, combined face lift approaches) should be evaluated carefully. Korean specialist surgeons typically offer this perspective when given the opportunity; clinics that don't are operating in surgery-volume mode rather than outcome mode.

If you do come, four practical notes. First, plan for the 21-day optimal stay rather than the 14-day minimum if your schedule allows; the second clinical check at day 7–10 catches issues that matter, and the more relaxed recovery materially reduces risk. Second, get the technique selection (L vs I osteotomy; intraoral-only vs combined arch), planned reduction in mm at multiple points, fixation type, and ptosis-mitigation plan documented in writing before the procedure. Third, plan for the 6-12 month outcome timeline mentally — the 2-week or 4-week result is not the final result. Fourth, the ptosis-risk conversation is critical for patients over 40; if the surgeon doesn't engage substantively with this, that's a signal to consider another consultation.

Zygoma reduction is one of the K-beauty procedures where Korean specialist experience, technique sophistication, and dollar economics align most strongly in Korea's favor for the right candidate. The consultation conversation that matters most is the technique-and-ptosis-risk conversation; the rest follows from there.